3-methoxytyramine has been researched along with Aging in 16 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder of mature and older individuals." | 1.36 | Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. ( Charlton, CG; King, J; Mackey, V; Muthian, G, 2010) |
| "The Fragile X syndrome, a common form of mental retardation in humans, is caused by silencing the fragile X mental retardation (FMR1) gene leading to the absence of the encoded fragile X mental retardation protein 1 (FMRP)." | 1.31 | Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. ( Braun, K; Gruss, M, 2001) |
| "Nomifensine treatment significantly increased TH enzyme amount in substantia nigra (39." | 1.30 | Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. ( Cano, J; Machado, A; Rodríguez-Gómez, JA; Romero-Ramos, M; Venero, JL, 1997) |
| "Biogenic amines in pons and striatum have been dosed in twenty-four months old Wistar male rats." | 1.27 | [Biochemical changes in 24-month-old Wistar rats]. ( Della Zuana, O; Duhault, J; Lonchampt, M; Roman, F; Saint Romas, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peitzsch, M | 1 |
| Mangelis, A | 1 |
| Eisenhofer, G | 1 |
| Huebner, A | 1 |
| Muthian, G | 1 |
| Mackey, V | 1 |
| King, J | 1 |
| Charlton, CG | 1 |
| Chanut, E | 1 |
| Labarthe, B | 1 |
| Lacroix, B | 1 |
| Noda, A | 1 |
| Gasdeblay, S | 1 |
| Bondier, JR | 1 |
| Versaux-Botteri, C | 1 |
| Roman, F | 1 |
| Della Zuana, O | 1 |
| Lonchampt, M | 1 |
| Saint Romas, G | 1 |
| Duhault, J | 1 |
| Venero, JL | 4 |
| Machado, A | 6 |
| Cano, J | 6 |
| Cabib, S | 1 |
| Puglisi-Allegra, S | 1 |
| D'Amato, FR | 1 |
| Romero-Ramos, M | 1 |
| Rodríguez-Gómez, JA | 1 |
| Gruss, M | 1 |
| Braun, K | 1 |
| Dalmaz, Y | 2 |
| Peyrin, L | 2 |
| Sann, L | 1 |
| Dutruge, J | 1 |
| Martineau, J | 1 |
| Garreau, B | 1 |
| Barthélémy, C | 1 |
| Jouve, J | 1 |
| Lelord, G | 1 |
| Godefroy, F | 1 |
| Bassant, MH | 1 |
| Lamour, Y | 1 |
| Weil-Fugazza, J | 1 |
| Santiago, M | 2 |
| Reinoso-Suárez, F | 1 |
16 other studies available for 3-methoxytyramine and Aging
| Article | Year |
|---|---|
Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Topics: Adolescent; Adrenal Gland Neoplasms; Aging; Blood Chemical Analysis; Catecholamines; Child; Child, P | 2019 |
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth | 2010 |
Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Animals, Newborn; Biogenic Monoamines; | 2006 |
[Biochemical changes in 24-month-old Wistar rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aging; Animals; Choline; Choline O-Acetyltrans | 1984 |
Effect of ageing on monoamine turnover in the prefrontal cortex of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Homovanillic Acid; Hy | 1993 |
Effects of postnatal stress on dopamine mesolimbic system responses to aversive experiences in adult life.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Apomorphine; Dopamine; Female; | 1993 |
Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibit | 1997 |
Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain St | 2001 |
[Relations between urinary 3-methoxytyramine and the peripheral metabolism of dopamine in human adults and children].
Topics: Adolescent; Adult; Aging; Child; Child, Preschool; Creatinine; Dopamine; Female; Humans; Infant; Inf | 1978 |
Age-related changes in catecholamine metabolites of human urine from birth to adulthood.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Aging; Catecholamines; Child; Child, Preschool; D | 1979 |
[Development in the metabolism of dopamine and its derivatives. Application to gross development disorders].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Autistic Disorder; Child; Child, Presch | 1992 |
Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydraz | 1991 |
Age effects on monoamine turnover of the rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Aromatic Amino Acid Decarboxyla | 1991 |
Effect of aging on dopamine metabolism in the rat cerebral cortex: a regional analysis.
Topics: Aging; Animals; Cerebral Cortex; Dopamine; Homovanillic Acid; Male; Norepinephrine; Rats; Rats, Inbr | 1991 |
Changes in biogenic amines in rat hippocampus during development and aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aging; Animals; Dopamine; Hippocampus; Homovani | 1988 |
Age-related changes of catecholamines and their metabolites content in the visual system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Catecholamines; Dopamine; Geniculate Bodies; Homovan | 1989 |